Series A Companies in South San Francisco

Boost Biomes develops microbial products to sustainably improve food production and shelf-life.

Atomic AI combines machine learning with structural biology to enable the design of RNA-targeted small molecules and RNA-based therapeutics.

Initial Therapeutics is a developer of small-molecule medicines designed to prevent pathogenic protein synthesis.

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.

Tacit Therapeutics created RNA-targeting treatments for devastating diseases.

Chariot Defense is creating the advanced hardware and software framework to solve it.

Discover the intent signals your CRM is missing

Tenvie Therapeutics is a biotechnology company that transforms the treatment of neurological diseases through engineered small molecules.

Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.

InterVene is a medical device company that treats severe venous disease in the legs.

Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment.

GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.

Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies.

Addition Therapeutics develops RNA-only therapeutics using PRINT technology for genetic medicine.

Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence.